CDC advisors recommend Pfizer’s maternal RSV vaccine in 11-1 vote

The CDC’s vaccine advisors on Friday afternoon voted 11-1 to recommend Pfizer’s maternal RSV vaccine for pregnant people at 32 to 36 weeks of gestation to prevent RSV in their infants.

The recommendation comes about a month after the FDA granted approval to the RSV vaccine, known as Abrysvo, for the same group of pregnant people.

Several committee members said that this recommendation was complicated by the fact that there will also be a monoclonal antibody available to give to infants to protect against RSV this upcoming season.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Dementia and Estrogen; Case Report on Fatality After Lecanemab; MRI-Based Brain Age

A nested case-control study showed that estrogen-only use in women was associated with a higher dementia rate compared with no estrogen use. (JAMA) Folate or

December 20, 2023

Unraveling the mysteries of gastro-esophageal junction development

The transition from the esophagus to the stomach is a delicate region from a medical point of view, often associated with pathological disorders leading to

April 13, 2024

Philips launches stent system to restore blood flow in blocked veins

Dive Brief: Philips has launched its Duo Venous Stent System in the U.S. to treat patients with blockages in their veins, the company said Wednesday.

June 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.